Literature DB >> 7509311

Cystic fibrosis in a low-incidence population: two major mutations in Finland.

J Kere1, X Estivill, M Chillón, N Morral, V Nunes, R Norio, E Savilahti, A de la Chapelle.   

Abstract

The incidence of cystic fibrosis (CF) in Finland, 1:25,000 newborn, is one of the lowest in Caucasian populations. The delta F508 mutation accounts for 18/40 (45%) of CF chromosomes in Finland. Other mutations were therefore sought among the remaining 55%. Twelve out of 40 chromosomes (30%) were found to carry 394delTT, whereas G542X and 3732delA were each detected in one chromosome. Eight mutations remained unidentified using a testing panel for 26 mutations. Mutation 394delTT was associated exclusively with haplotype 23-36-13. Five unknown mutations were associated with different haplotypes for microsatellite markers, whereas three shared the same haplotype. Most delta F508 mutations and all unidentified mutations originated from regions of old and dense settlement in the coastal regions, whereas 394delTT was geographically clustered and enriched in a rural location, consistent with a local founder effect. The remote location of Finland and her population history give a plausible explanation for the rarity of CF in Finland.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509311     DOI: 10.1007/bf00210603

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations.

Authors:  P Gasparini; A Bonizzato; M Dognini; P F Pignatti
Journal:  Mol Cell Probes       Date:  1992-02       Impact factor: 2.365

2.  Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

Authors: 
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

3.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

4.  Cystic fibrosis in Finland: a molecular and genealogical study.

Authors:  J Kere; R Norio; E Savilahti; X Estivill; A de la Chapelle
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

Review 5.  Hereditary diseases in Finland; rare flora in rare soul.

Authors:  R Norio; H R Nevanlinna; J Perheentupa
Journal:  Ann Clin Res       Date:  1973-06

6.  Cystic fibrosis mutation delta F508 in Finland: other mutations predominate.

Authors:  J Kere; E Savilahti; R Norio; X Estivill; A de la Chapelle
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

7.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

8.  Multiplex PCR amplification of three microsatellites within the CFTR gene.

Authors:  N Morral; X Estivill
Journal:  Genomics       Date:  1992-08       Impact factor: 5.736

9.  Cystic fibrosis in the Basque country: high frequency of mutation delta F508 in patients of Basque origin.

Authors:  T Casals; C Vázquez; C Lázaro; E Girbau; F J Giménez; X Estivill
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

Review 10.  Human genomic diversity in Europe: a summary of recent research and prospects for the future.

Authors:  L L Cavalli-Sforza; A Piazza
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

View more
  6 in total

1.  A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays.

Authors:  T Pastinen; M Raitio; K Lindroos; P Tainola; L Peltonen; A C Syvänen
Journal:  Genome Res       Date:  2000-07       Impact factor: 9.043

2.  Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population.

Authors:  E Laiho; J Ignatius; H Mikkola; V C Yee; D C Teller; K M Niemi; U Saarialho-Kere; J Kere; A Palotie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Elinor Langfelder-Schwind; Edward Kloza; Elaine Sugarman; Barbara Pettersen; Trisha Brown; Kim Jensen; Seth Marcus; Joy Redman
Journal:  J Genet Couns       Date:  2005-02       Impact factor: 2.537

Review 4.  Newborn Screening for CF across the Globe-Where Is It Worthwhile?

Authors:  Virginie Scotet; Hector Gutierrez; Philip M Farrell
Journal:  Int J Neonatal Screen       Date:  2020-03-04

Review 5.  The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery.

Authors:  Virginie Scotet; Carine L'Hostis; Claude Férec
Journal:  Genes (Basel)       Date:  2020-05-26       Impact factor: 4.096

6.  Cystic Fibrosis Polymorphic Variants in a Russian Population.

Authors:  Anna Kiseleva; Marina Klimushina; Evgeniia Sotnikova; Alexey Meshkov; Oxana Drapkina; Olga Skirko; Mikhail Divashuk; Olga Kurilova; Alexandra Ershova; Eleonora Khlebus; Anastasia Zharikova; Irina Efimova; Maria Pokrovskaya; Petr A Slominsky; Svetlana Shalnova
Journal:  Pharmgenomics Pers Med       Date:  2020-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.